OptimizeRx Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
OptimizeRx Stock Forecast and Price Target
The average target price set lately by five experts for OptimizeRx to reach by the end of the year is $16.00, which would imply a potential upside of approximately 53.55 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $20.00 and a low estimate of $13.00. If you want to invest in OPRX stock, you might also want to take a look at how its competitors are doing.
53.55% Upside
OptimizeRx Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, OptimizeRx's Price has gone down from $11.56 to $0.00 – a 100.00% drop. For next year, analysts predict Fair Value of $20.07, which would mean an increase of 100.00%. Over the next seven years, experts predict that OptimizeRx's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HSTM Stock Forecast | HealthStream | Outperform |
16
|
$26.07 | Buy/Sell | $31.67 | 22.75% |
| HCAT Stock Forecast | Health Catalyst | Outperform |
7
|
$6.31 | Buy/Sell | $11.92 | 82.25% |
| SPOK Stock Forecast | Spok Holdings | Buy |
8
|
$15.72 | Buy/Sell | $15.50 | 14.50% |
| CPSI Stock Forecast | Computer Programs and Systems | Outperform |
18
|
$8.06 | Buy/Sell | $16.50 | 48.88% |
| CCLD Stock Forecast | CareCloud | Buy |
0
|
$1.11 | Buy/Sell | $3.88 | 192.79% |
OptimizeRx Revenue Forecast for 2023 - 2025 - 2030
In the last two years, OptimizeRx's Revenue has grown by 44.19%, rising from $43.31M to $62.45M. For next year, analysts predict Revenue of $110.12M, which would mean an increase of 76.33%. Over the next seven years, experts predict that OptimizeRx's Revenue will grow at a rate of 66.34%.
.jpg)
OptimizeRx EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, OptimizeRx's EBITDA has decreased by 1680.00%, going from $650.00k to $-10.27M. 5 analysts predict OptimizeRx's EBITDA will decrease by 211.98% in the next year, reaching $11.50M. By 2030, professionals predict that OptimizeRx's EBITDA will decrease by 222.52%, to $12.58M.
OptimizeRx EBIT Forecast for 2023 - 2025 - 2030
OptimizeRx's EBIT has seen impressive growth In the last two years, rising from $-1.32M to $-12.29M – a growth of 831.06%. For the following year, the 4 analysts predict that OptimizeRx's EBIT will drop by 28.32%, reaching $-8.81M. In 2030, the professionals' prediction is that OPRX's EBIT will decrease by 29.74%, reaching $-8.63M.
OptimizeRx EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, OptimizeRx's EPS has gone down from $0.19 to $0.00 – a 100.00% drop. For next year, analysts predict EPS of $0.33, which would mean an increase of 100.00%. Over the next seven years, experts predict that OptimizeRx's EPS will grow at a rate of 100.00%.
.jpg)